37
Tim Irish Analysts’ Meeting June 15 th , 2005 Current Market Dynamics and Future Vision of the Care Cycle

Current Market Dynamics and Future Vision of the Care Cycle

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Current Market Dynamics and Future Vision of the Care Cycle

Tim Irish

Analysts’ Meeting June 15th, 2005

Current Market Dynamics andFuture Vision of the Care Cycle

Page 2: Current Market Dynamics and Future Vision of the Care Cycle

2Philips Medical Systems

Overview

• Market and Customer trends

• The Care Cycle and Molecular Medicine

Page 3: Current Market Dynamics and Future Vision of the Care Cycle

3Philips Medical Systems

Healthcare Expenditures will grow from ~8% of worldwide GDP to ~10% in 2010

49%

28%

8%

2%

13%

North AmericaWestern EuropeJapanChina/Hong KongRest of the World

Worldwide Healthcare Expenditure: US$3,300 bln in 2002

North America makes up 49%of the worldwide spent

Source: Medistat

0 %

2 %

4 %

6 %

8 %

1 0 %

1 9 5 0 2 0 0 0 2 0 1 0Source: WHO

Healthcare is the world’s largest service sector

Page 4: Current Market Dynamics and Future Vision of the Care Cycle

4Philips Medical Systems

1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050

50%

40%

30%

20%

10%

0%

12%

20%

30%

1950 2000 2050

% of people over 60 years, Western World

Sources: United Nations, Victor R. Fuchs (Stanford University)

1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050

50%

40%

30%

20%

10%

0%

12%

20%

30%

1950 2000 2050

% of people over 60 years, Western World

Sources: United Nations, Victor R. Fuchs (Stanford University)

Demographics and economic developments add to long term growth

As national economies develop, healthcare investments follow…

Page 5: Current Market Dynamics and Future Vision of the Care Cycle

5Philips Medical Systems

1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050

50%

40%

30%

20%

10%

0%

12%

20%

30%

1950 2000 2050

% of people over 60 years, Western World

Sources: United Nations, Victor R. Fuchs (Stanford University)

1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050

50%

40%

30%

20%

10%

0%

12%

20%

30%

1950 2000 2050

% of people over 60 years, Western World

Sources: United Nations, Victor R. Fuchs (Stanford University)

Share of Medical Expenditure

Demographics and economic developments add to long term growth

Source: Medistat

As national economies develop, healthcare investments follow…

All other countries Top 5 countries

Page 6: Current Market Dynamics and Future Vision of the Care Cycle

6Philips Medical Systems

$1 of Healthcare creates $2.5 of economic value through better outcomes

Source: Medtap report, The Value of Investment in Healthcare, 2005

Page 7: Current Market Dynamics and Future Vision of the Care Cycle

7Philips Medical Systems

Healthcare delivers huge benefits

• Benefits from increased spendings since 1980, USA:

• From a human perspective: – 470,000 less deaths– 2,300,000 less people with

disabilities– 206,000,000 days less spent in

hospital• From an economic perspective:

– Delivering $ 1600 bln of economic value

Source: Medtap report, The Value of Investment in Healthcare, 2005

Iron lungs during Polio epidemic in the 1950’s

Page 8: Current Market Dynamics and Future Vision of the Care Cycle

8Philips Medical Systems Sources: Russ Coile, Futurescan 2003, SG-2

Imagingearlier diagnosis saves lives and reduces costs

Minimally invasive surgeryreducing patient trauma and costs

Healthcare ITRight Information at the right time

enables better treatment and lower costs

Molecular MedicinePreventing disease from happening

Medical technology continues to transform Healthcare

Around 70% of the survival improvement in heart attack mortality is a result of changes in technology.” Cutler & McClellan, 2001

Page 9: Current Market Dynamics and Future Vision of the Care Cycle

9Philips Medical Systems

“Imaging is key to lower Healthcare costs and improved patient outcome”Imaging is about:• Better diagnosis for better treatment• Earlier detection to catch disease early • Minimally invasive surgery to avoid trauma

and shorten procedure time McKinsey, 2004

“Continued advances in Imaging modalities will transform medicine during this decade”SG-2, 2004

Page 10: Current Market Dynamics and Future Vision of the Care Cycle

10Philips Medical Systems

$1 of imaging saved $ 3 in hospital costs

- 4%Imaging costs/patient

12%Increase in number of patients imaged

8%8%cost growthImaging costsHospital costs6 year CAGR

Beinfeld et al., Radiology, 2005; 17,200 patients, 1996 – 2002

Big cost savings by Imaging in large teaching hospital

Page 11: Current Market Dynamics and Future Vision of the Care Cycle

11Philips Medical Systems

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Ever expanding range of clinical applications

Page 12: Current Market Dynamics and Future Vision of the Care Cycle

12Philips Medical Systems

Diagnosis of blood vessels –Heart, Brain, Body; skeletal trauma (e.g., broken bones), chest & lungs, gastro-intestines (digestive tract), high-resolution mammography

Ever expanding range of clinical applications

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Page 13: Current Market Dynamics and Future Vision of the Care Cycle

13Philips Medical Systems

Cardiology:Detection, diagnosis and treatment of heart disease, heart attack, acute stroke, vascular disease;Ob/gyn;General Body: kidneys, liver, thyroid, and blood vessels. Also being used for breast imaging

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Ever expanding range of clinical applications

Page 14: Current Market Dynamics and Future Vision of the Care Cycle

14Philips Medical Systems

Ever expanding range of clinical applications

Cardiac & Vascular;NeurologicDiagnosis;Pelvic/abdominal, Spine, Lungs; Accidents/trauma casesCancer Detection;CT Angiography (CTA)

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Page 15: Current Market Dynamics and Future Vision of the Care Cycle

15Philips Medical Systems

Ever expanding range of clinical applications

Soft tissue, suchas the brain and nervous system;Spine, skeleton, joints: bone, cartilage, ligament, tendon, and images of inside the bone;Cardiovascular/angiography: (MRA);‘Functional’ fMRI;Abdominal;Pediatric

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Page 16: Current Market Dynamics and Future Vision of the Care Cycle

16Philips Medical Systems

Ever expanding range of clinical applications

SPECT:Coronary artery disease;Bones, lungs, brain, blood, gastrointestinal organsPET:Primary cancer and metastases;Neurology –stroke, Alzheimer’s, Parkinson’s

X-Ray

Ultrasound

CT

MR

Nuclear Medicine

Page 17: Current Market Dynamics and Future Vision of the Care Cycle

17Philips Medical Systems

Growth in imaging procedures driven by innovations in technology & clinical applications

0

50

100

150

200

250

300

350

400

450

1963 1973 1983 1993 2003

NM

CT

MR

US

CV X-Ray

GeneralX-Ray

Avg. 10-Year CAGR

15%

25%

10%

5%

6%

2%

TOTAL 4%

Total Excl GXR 10%Source: Frost & Sullivan

Page 18: Current Market Dynamics and Future Vision of the Care Cycle

18Philips Medical Systems

02000400060008000

100001200014000160001800020000

2004 2014

MR heartCT bloodvesselsCT chestMR spineCT abdomen

Procedure Volume will continue to grow….Example: USA

8%

5%7%

26%13%

Source: SG2, June 2005

Page 19: Current Market Dynamics and Future Vision of the Care Cycle

19Philips Medical Systems

Creating long term growth in Imaging Market

Growth of Diagnostic imaging equipment market (orders)

0

2000

4000

6000

8000

10000

12000

14000

16000

18000

1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

US$

Asia/Pac.(rest of)JapanLatin AmericaEMEANA

Source: Nema, Cocir, JIRA, PMS analysis

On average by 5% per year

Page 20: Current Market Dynamics and Future Vision of the Care Cycle

20Philips Medical Systems

Customer Dynamics

Continuation of established trends• Privatization of Healthcare• Consumerism• Pay-for-Performance programs• Staffing shortages • Productivity opportunities

through new technology• Increased New hospital

construction

New dynamics are becoming manifest:• More large, multiyear,

partnership deals with higher margins and risks– Strategic partnerships

Page 21: Current Market Dynamics and Future Vision of the Care Cycle

21Philips Medical SystemsSource: Healthcare Advisory Board 2004

45% 44% 42% 41% 41% 40% 41% 41%

56% 58% 59% 59% 60% 59% 59%

1998 1999 2000 2001 2002 2003 2004

Percent of Hospitals with Positive Margins

Percent of Hospitalswith Negative Margins

0% Medicare Margin

Hospitals and Health care systems continue to be financially challenged. Example: USA

Page 22: Current Market Dynamics and Future Vision of the Care Cycle

22Philips Medical Systems

Community hospitals in the USASimilar trends in many Western countries

Customers are slowly consolidating

Source: American Hospital Association, 312-422-3000, sha.org

Number of Community HospitalsTotal number of hospitals and beds

840

880

870

860

850

830

8201995 1996 1997 1998 1999 200 2001 2002

5,194

5,134

5,0575,015

4,9564,915 4,908 4,927

Page 23: Current Market Dynamics and Future Vision of the Care Cycle

23Philips Medical Systems

Capital Financing:Full-service financing

resources include strategies for tax-free capital and variable

term financing

Support and Services:Biomedical service and a

complete program of consulting and marketing

assistance for your facility

Construction and Planning:Coordination of all aspects of new

facility planning and implementation thru a consortium of industry experts

Technology Procurement:Alliance-level pricing for

products and services and ongoing technology availability

updates Research:Mutually significant projects and collaborations defined with short and long-term objectives

Education and Training:Philips offers a comprehensive on-line CE program to keep technologist credits up to date. New-user physician training programs provide revenue generation opportunities

Partnership Elements

Buying needs are changing towards longer term partnerships

Page 24: Current Market Dynamics and Future Vision of the Care Cycle

24Philips Medical Systems

University of Alabama, Birmingham

Univ.

20th

6th

UAB Campus Master PlanUAB Campus Master Plan

18th

Today• Largest University Health System

in Southeastern United States

• Complex includes 5 City Blocks• 2.1 Million Square Feet• 13 Major Free Standing Buildings

2010• 75 City Blocks• 12 Million Square Feet• 17 Free Standing Buildings

Page 25: Current Market Dynamics and Future Vision of the Care Cycle

25Philips Medical Systems

Overview

• Market and Customer trends

• The Care Cycle and Molecular Medicine

Page 26: Current Market Dynamics and Future Vision of the Care Cycle

26Philips Medical Systems

Changing Care Cycle: Liver Cancer

Information &Decision support

Follow Up

Diagnostics

Therapy

Lab

Symptoms

Ward

ICU

Rest in Peace

Surgery

Page 27: Current Market Dynamics and Future Vision of the Care Cycle

27Philips Medical Systems

Changing Care Cycle: Liver Cancer

Information &Decision support

Follow Up

Diagnostics

Therapy

Lab

Symptoms

Page 28: Current Market Dynamics and Future Vision of the Care Cycle

28Philips Medical Systems

Changing Care Cycle: Stroke

Information &Decision support

Follow Up

Diagnostics

Therapy

Symptoms

Rest in Peace

40% Mortalitytoday

SurgeryICU

Ward

Ward

30% loss of independence

Page 29: Current Market Dynamics and Future Vision of the Care Cycle

29Philips Medical Systems

Changing Care Cycle: Stroke

Information &Decision support

Follow Up

Diagnostics

Therapy

Page 30: Current Market Dynamics and Future Vision of the Care Cycle

30Philips Medical Systems

The ingredients of Molecular MedicineBiomarkers In Vitro Diagnostics Image-guidedDiscovery In Vivo Imaging therapeutic agents

Linking disease to bio-molecules

Courtesy: Ciphergen

Targeted therapeuticsDiagnosing Disease

Page 31: Current Market Dynamics and Future Vision of the Care Cycle

31Philips Medical Systems

Changing Care Cycle: Preventing heart attacks

Information &Decision support

Follow Up

Diagnostics

Therapy

Page 32: Current Market Dynamics and Future Vision of the Care Cycle

32Philips Medical Systems

…Breakthrough in Biochips for molecular biomarkers

Building on Philips competences:• Sensitive and compact magnetic

detection techniques • Magnetic nanoparticles as detection

probes for bio-molecules • Semiconductor technology• Order of magnitude more sensitive

than current technologies

Page 33: Current Market Dynamics and Future Vision of the Care Cycle

33Philips Medical Systems

Philips unique‘Lab-on-a-chip’ solution

Size: ~10 x12 cm0,5 micron structures

…Tomorrow’s Modality: new Molecular Diagnostics platforms

To fight sepsis:

• An estimated >1.5 mio sepsis cases (US and Europe only) every year in hospitals with an increasing rate of mortality

• Utilizing Philips in-house competencies in Miniaturization and Integration, to reduce diagnosis from days to hours

Page 34: Current Market Dynamics and Future Vision of the Care Cycle

34Philips Medical Systems

…Tomorrow’s Modality Today: Unique Molecular Imaging platform…

First high end SPECT-CT Unique information

Page 35: Current Market Dynamics and Future Vision of the Care Cycle

35Philips Medical Systems

To build the new Medical Paradigm: Molecular Medicine

The Future

Your own biochemistry becomes the basis for diagnosis and treatment

Molecular imaging will screen people with genetically inherited & life-style risks

Page 36: Current Market Dynamics and Future Vision of the Care Cycle

36Philips Medical Systems

Conclusions

• Healthcare and medical technology add both human and economic value

• Very predictable growth outlook based on established growth drivers (demographics, chronic illness, technology, privatization and consumerism)

• Technology innovation to accelerate – ever faster, ever more accurate and much earlier (more screening)

• The future lies in linking new technology applications to the Care Cycle

• Massive opportunities to increase both clinical outcomes and health economics through Care Cycle improvements

Page 37: Current Market Dynamics and Future Vision of the Care Cycle

37Philips Medical Systems